| 1 |
Jian FX, Bao PX, Li WF, Cui YH, Hong HG. Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery. BMC Cancer 2023;23:269. [PMID: 36964570 DOI: 10.1186/s12885-023-10738-0] [Reference Citation Analysis]
|
| 2 |
Gheybi E, Asoodeh A, Amani J. Preparation of chitosan nanoparticle containing recombinant CD44v antigen and evaluation of its immunization capacity against breast cancer in BALB/c mice. BMC Cancer 2023;23:134. [PMID: 36759786 DOI: 10.1186/s12885-023-10614-x] [Reference Citation Analysis]
|
| 3 |
Mardhekar S, Subramani B, Samudra P, Srikanth P, Mahida V, Ravindra Bhoge P, Toraskar S, Abraham NM, Kikkeri R. Sulfation of Heparan and Chondroitin Sulfate Ligands Enables Cell-Specific Homing of Nanoprobes. Chemistry 2023;29:e202202622. [PMID: 36325647 DOI: 10.1002/chem.202202622] [Reference Citation Analysis]
|
| 4 |
Dubashynskaya NV, Gasilova ER, Skorik YA. Nano-Sized Fucoidan Interpolyelectrolyte Complexes: Recent Advances in Design and Prospects for Biomedical Applications. Int J Mol Sci 2023;24. [PMID: 36768936 DOI: 10.3390/ijms24032615] [Reference Citation Analysis]
|
| 5 |
Kousar K, Naseer F, Abduh MS, Kakar S, Gul R, Anjum S, Ahmad T. Green synthesis of hyaluronic acid coated, thiolated chitosan nanoparticles for CD44 targeted delivery and sustained release of Cisplatin in cervical carcinoma. Front Pharmacol 2022;13:1073004. [PMID: 36712656 DOI: 10.3389/fphar.2022.1073004] [Reference Citation Analysis]
|
| 6 |
Chen X, Yang R, Shen J, Huang Q, Wu Z. Research Progress of Bioinspired Nanostructured Systems for the Treatment of Ocular Disorders. Pharmaceuticals (Basel) 2023;16. [PMID: 36678597 DOI: 10.3390/ph16010096] [Reference Citation Analysis]
|
| 7 |
Shaban NZ, El-Faham AA, Abu-Serie MM, Habashy NH. Targeting apoptosis in MCF-7 and Ehrlich ascites carcinoma cells by saponifiable fractions from green and black Vitis vinifera seed oil. Biomed Pharmacother 2023;157:114017. [PMID: 36395612 DOI: 10.1016/j.biopha.2022.114017] [Reference Citation Analysis]
|
| 8 |
Chianese G, Fasolino I, Tramontano C, De Stefano L, Imparato C, Aronne A, Ambrosio L, Raucci MG, Rea I. ROS-Generating Hyaluronic Acid-Modified Zirconium Dioxide-Acetylacetonate Nanoparticles as a Theranostic Platform for the Treatment of Osteosarcoma. Nanomaterials (Basel) 2022;13. [PMID: 36615964 DOI: 10.3390/nano13010054] [Reference Citation Analysis]
|
| 9 |
Kalyane D, Polaka S, Vasdev N, Tekade RK. CD44-Receptor Targeted Gold-Doxorubicin Nanocomposite for Pulsatile Chemo-Photothermal Therapy of Triple-Negative Breast Cancer Cells. Pharmaceutics 2022;14. [PMID: 36559228 DOI: 10.3390/pharmaceutics14122734] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Jian FX, Bao PX, Li WF, Cui YH, Hong HG. Negative regulation of CD44st by miR-138-5p affects the invasive ability of breast cancer cells and patient prognosis after breast cancer surgery.. [DOI: 10.21203/rs.3.rs-2272278/v1] [Reference Citation Analysis]
|
| 11 |
Lu X, Wang X, Li A, Zhou T, Zhang L, Qu J, Mao Z, Gu X, Zhang X, Jing S. Ferrocenylseleno-dopamine functionalized carbon dots for redox-gated imaging and drug delivery in cancer cells. Dyes and Pigments 2022;205:110586. [DOI: 10.1016/j.dyepig.2022.110586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
